These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28035005)

  • 21. Regulation by the extracellular matrix (ECM) of prolactin-induced alpha s1-casein gene expression in rabbit primary mammary cells: role of STAT5, C/EBP, and chromatin structure.
    Jolivet G; Pantano T; Houdebine LM
    J Cell Biochem; 2005 May; 95(2):313-27. PubMed ID: 15778982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter.
    Fang F; Antico G; Zheng J; Clevenger CV
    BMC Biotechnol; 2008 Feb; 8():11. PubMed ID: 18254957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
    Pedraz-Cuesta E; Fredsted J; Jensen HH; Bornebusch A; Nejsum LN; Kragelund BB; Pedersen SF
    Mol Endocrinol; 2016 Jul; 30(7):693-708. PubMed ID: 27176613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The modulation of adiponectin by STAT5-activating hormones.
    White UA; Maier J; Zhao P; Richard AJ; Stephens JM
    Am J Physiol Endocrinol Metab; 2016 Jan; 310(2):E129-36. PubMed ID: 26601851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells.
    Buser AC; Gass-Handel EK; Wyszomierski SL; Doppler W; Leonhardt SA; Schaack J; Rosen JM; Watkin H; Anderson SM; Edwards DP
    Mol Endocrinol; 2007 Jan; 21(1):106-25. PubMed ID: 16973758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
    Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
    J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
    Ferrag F; Chiarenza A; Goffin V; Kelly PA
    Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
    Jabbour HN; Critchley HO; Boddy SC
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin regulates LAT1 expression via STAT5 (signal transducer and activator of transcription 5) signaling in mammary epithelial cells of dairy cows.
    Zhou J; Jiang M; Shi Y; Song S; Hou X; Lin Y
    J Dairy Sci; 2020 Jul; 103(7):6627-6634. PubMed ID: 32389479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha
    Castillo LF; Rivero EM; Goffin V; Lüthy IA
    Cell Signal; 2017 Jun; 34():76-85. PubMed ID: 28302567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmented Stat5 Signaling Bypasses Multiple Impediments to Lactogen-Mediated Proliferation in Human β-Cells.
    Chen H; Kleinberger JW; Takane KK; Salim F; Fiaschi-Taesch N; Pappas K; Parsons R; Jiang J; Zhang Y; Liu H; Wang P; Bender AS; Frank SJ; Stewart AF
    Diabetes; 2015 Nov; 64(11):3784-97. PubMed ID: 26159175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
    Nevalainen MT; Xie J; Bubendorf L; Wagner KU; Rui H
    Mol Endocrinol; 2002 May; 16(5):1108-24. PubMed ID: 11981045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
    Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
    Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription.
    Han Y; Watling D; Rogers NC; Stark GR
    Mol Endocrinol; 1997 Jul; 11(8):1180-8. PubMed ID: 9212064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.
    Russell DL; Richards JS
    Mol Endocrinol; 1999 Dec; 13(12):2049-64. PubMed ID: 10598581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of prolactin and glucocorticoid signaling at the beta-casein promoter and enhancer by ordered recruitment of specific transcription factors and chromatin modifiers.
    Kabotyanski EB; Huetter M; Xian W; Rijnkels M; Rosen JM
    Mol Endocrinol; 2006 Oct; 20(10):2355-68. PubMed ID: 16772529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin and interleukin-2 receptors in T lymphocytes signal through a MGF-STAT5-like transcription factor.
    Gouilleux F; Moritz D; Humar M; Moriggl R; Berchtold S; Groner B
    Endocrinology; 1995 Dec; 136(12):5700-8. PubMed ID: 7588326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
    Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
    J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.